View in EDS HTML Full Text PDF Full Text

Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.

Saved in:
Bibliographic Details
Title: Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.
Authors: Luczkowiak J; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain., Rivas G; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain., Labiod N; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain., Lasala F; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain., Rolo M; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain., Lora-Tamayo J; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain., Mancheno-Losa M; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain., Rial-Crestelo D; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain., Pérez-Rivilla A; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain., Folgueira MD; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain., Delgado R; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain.
Source: Journal of medical virology [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28268. Date of Electronic Publication: 2022 Nov 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1096-9071
DOI:10.1002/jmv.28268